By
Trending Posts
How are NVIDIA & Taiwan’s 22 Medical Centers…
May 18, 2025 In a landmark initiative signaling the rapid digital transformation of Asia’s healthcare ecosystem, several leading…
BioNTech to Launch £1 Billion AI-Powered R&D Hub…
Investment to Accelerate AI Innovation in Oncology, Personalized Medicine, and Drug Development May 21, 2025 Establishing an AI-Centric…
Regeneron, Sanofi & Viz.ai: How Are These Industry…
May 20, 2025 In a bold strategic alliance, Regeneron and Sanofi have teamed up with AI healthcare innovator…
How RevolKa’s $1.7M Series A Extension Fuels AI-Driven…
Sendai, Japan – May 20, 2025 RevolKa Ltd., a fast-growing biotechnology company leveraging AI for protein engineering, has…
Foxconn and NVIDIA: How Can AI-Driven Robotics Address…
May 18, 2025 In response to the World Health Organization’s projection of a 4.5 million nurse shortage by…
Is Quantum AI the Future of RNA Drug…
Key Highlights: INDIANAPOLIS, IN & SAN DIEGO, CA – In a major signal of the industry’s growing confidence…
Johnson & Johnson MedTech and Qure.ai Partner to…
May 10, 2025 – IndiaJohnson & Johnson MedTech has announced a strategic collaboration with healthcare AI innovator Qure.ai…
Can Eli Lilly and Purdue University reshape pharmaceutical…
The initiative will focus on applying artificial intelligence, robotics, and data science to improve every stage of the…
AI-driven ALS therapy: How Eli Lilly is expanding…
Key highlights AI-powered discovery enters clinical stageEli Lilly and Company has entered into a licensing agreement with Alchemab…
Trending Posts
Latest Stories
Can Novartis and BioArctic’s $802M Alliance Unlock the Next Breakthrough in Neurodegenerative Drug Delivery?
Key Highlights Strategic Collaboration Targets Neurodegenerative DiseasesNovartis has entered into a research partnership with Sweden’s…
Can IQVIA and Flagship Pioneering’s AI-Driven Alliance Unlock the Next $60B Wave of Breakthrough Biopharma?
Key Highlights AI-Powered Acceleration in Drug DevelopmentThe collaboration positions IQVIA’s Healthcare-grade AI® and data-driven analytics…
Could Halda Therapeutics and VantAI’s $1B AI Alliance Redefine the Future of Cancer Drug Discovery?
Key Highlights Strategic Alliance to Advance Induced Proximity TherapiesHalda Therapeutics has entered into a collaboration…
How AbbVie Is Expanding Its Psychiatry Pipeline Through $1.2B Acquisition of Gilgamesh Pharmaceuticals’s Next-Gen Depression Drug?
Key Highlights The Promise of BretisilocinBretisilocin (GM-2505) is a novel, short-acting 5-HT2A receptor agonist and…
Gallery
